Patient & Visitor InformationContact Us
  • Cantos Study

  • The purpose is to find out if the study drug Canakinumab, which reduces inflammation, is both safe and beneficial in reducing future cardiovascular events (such as heart attacks and strokes) in patients who have had a heart attack and have ongoing increased inflammation.  This study will also test whether or not Canakinumab reduces the development of Type 2 diabetes (often called adult onset diabetes) if the patient had abnormal blood sugar levels after heart attack.

    For more information, please contact:
    Cardiovascular Research
    The Miriam Hospital
    Lori-Ann DeSimone
    401-793-4105